UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Targeted Sequencing of Plasma-Derived vs. Urinary cfDNA from Patients with Triple-Negative Breast Cancer

Cancers, 2022-08, Vol.14 (17), p.4101

2022

Volltextzugriff (PDF)

Desmoplasia in cervical cancer is associated with a more aggressive tumor phenotype

Scientific reports, 2023-11, Vol.13 (1), p.18946-18946, Article 18946

2023

Volltextzugriff (PDF)

Combined Analysis of Disseminated Tumor Cells (DTCs) and Circulating Tumor DNA (ctDNA) in a Patient Suffering from Triple Negative Breast Cancer Revealed Elevated Risk

Frontiers in bioscience (Landmark. Print), 2022-06, Vol.27 (7), p.208

2022

Volltextzugriff (PDF)

Heterogeneity between Core Needle Biopsy and Synchronous Axillary Lymph Node Metastases in Early Breast Cancer Patients-A Comparison of HER2, Estrogen and Progesterone Receptor Expression Profiles during Primary Treatment Regime

Cancers, 2022-04, Vol.14 (8), p.1863

2022

Volltextzugriff (PDF)

Circulating Tumor Cell Composition in Renal Cell Carcinoma

PloS one, 2016-04, Vol.11 (4), p.e0153018-e0153018

2016

Volltextzugriff (PDF)

Multi-Parameter Analysis of Disseminated Tumor Cells (DTCs) in Early Breast Cancer Patients with Hormone-Receptor-Positive Tumors

Cancers, 2023-01, Vol.15 (3), p.568

2023

Volltextzugriff (PDF)

Detection of circulating tumor cell subpopulations in patients with head and neck squamous cell carcinoma (HNSCC)

PloS one, 2014-12, Vol.9 (12), p.e113706-e113706

2014

Volltextzugriff (PDF)

The Mechanical Fingerprint of Circulating Tumor Cells (CTCs) in Breast Cancer Patients

Cancers, 2021-03, Vol.13 (5), p.1119

2021

Volltextzugriff (PDF)

FOXM1 Inhibition in Ovarian Cancer Tissue Cultures Affects Individual Treatment Susceptibility Ex Vivo

Cancers, 2021-02, Vol.13 (5), p.956

2021

Volltextzugriff (PDF)

The Challenge to Stabilize, Extract and Analyze Urinary Cell-Free DNA (ucfDNA) during Clinical Routine

Diagnostics (Basel), 2023-12, Vol.13 (24), p.3670

2023

Volltextzugriff (PDF)

Abstract P2-01-16: Targeted sequencing of plasma-derived vs. urinary cfDNA from patients with triple negative breast cancer

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P2-P2-01-16

2022

Volltextzugriff (PDF)

Analysis of disseminated tumor cells (DTCs) in primary breast cancer patients with various molecular subtypes

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e13000-e13000

2021

Volltextzugriff (PDF)

In search for new targets: Differences of HER2 receptor expression between CNB and synchronous axillary lymph node metastases in 205 patients

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e12559-e12559

2023

Volltextzugriff (PDF)

Abstract 4604: Can breast cancer cells be distinguished from blood cells by mechanical parameters? A label-free CTC detection approach

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.4604-4604

2020

Volltextzugriff (PDF)

Can tumor cells be distinguished from blood cells by mechanical parameters? A label-free CTC detection approach

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e15526-e15526

2020

Volltextzugriff (PDF)

Abstract P1-03-01: Heterogeneity between core needle biopsy and primary tumor tissue in early breast cancer patients: Comparison of intrinsic subtypes after different treatment regimes

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P1-P1-03-01

2022

Volltextzugriff (PDF)

Heterogeneity between core needle biopsy and synchronous axillary lymph node metastases in early breast cancer patients: Comparison of HER2, estrogen and progesterone receptor expression profiles during primary treatment regime

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e12565-e12565

2021

Volltextzugriff (PDF)

Development of a personalized ex vivo drug screening test for patients with ovarian cancer

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e18090-e18090

2020

Volltextzugriff (PDF)

Die CAPTOR-BC-Studie

Senologie (Stuttgart), 2024-09, Vol.21 (3), p.194-196

2024

Volltextzugriff (PDF)

An Observational Study on Breast Cancer Survival and Lifestyle Related Risk Factors

In vivo (Athens), 2021-03, Vol.35 (2), p.1007-1015

2021

Volltextzugriff (PDF)

Abstract 6693: Stability of urinary cell-free DNA and detection of T790M variant

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.6693-6693

2023

Volltextzugriff (PDF)

Individual profiling of circulating tumor cell composition in patients with non-small cell lung cancer receiving platinum based treatment

Translational lung cancer research, 2014-04, Vol.3 (2), p.100-106

2014

Volltextzugriff (PDF)

The Potential Use of Urinary CtDNA Profiling in the Treatment of Breast Cancer

World Journal of Gynecology & Womens Health, 2020-08, Vol.4 (3)

Ivonne, Nel

2020

Volltextzugriff (PDF)

Circulating tumor cell composition and outcome in patients with solid tumors

International journal of clinical pharmacology and therapeutics, 2014-01, Vol.52 (1), p.74-75

2014

Volltextzugriff (PDF)

1 – 25 von 40

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(39)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(6)
Cancers
(5)
Cancer Research
(4)
Giornale Storico Della Letteratura Italiana
(4)
Plos One
(2)
Translational Oncology
(2)
Biomarkers In Medicine
(1)
British Journal Of Dermatology
(1)
Diacronie
(1)
Diagnostics
(1)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Targeted Sequencing of Plasma-Derived vs. Urinary cfDNA from Patients with Triple-Negative Breast Cancer

Desmoplasia in cervical cancer is associated with a more aggressive tumor phenotype

Combined Analysis of Disseminated Tumor Cells (DTCs) and Circulating Tumor DNA (ctDNA) in a Patient Suffering from Triple Negative Breast Cancer Revealed Elevated Risk

Heterogeneity between Core Needle Biopsy and Synchronous Axillary Lymph Node Metastases in Early Breast Cancer Patients-A Comparison of HER2, Estrogen and Progesterone Receptor Expression Profiles during Primary Treatment Regime

Circulating Tumor Cell Composition in Renal Cell Carcinoma

Multi-Parameter Analysis of Disseminated Tumor Cells (DTCs) in Early Breast Cancer Patients with Hormone-Receptor-Positive Tumors

Detection of circulating tumor cell subpopulations in patients with head and neck squamous cell carcinoma (HNSCC)

The Mechanical Fingerprint of Circulating Tumor Cells (CTCs) in Breast Cancer Patients

FOXM1 Inhibition in Ovarian Cancer Tissue Cultures Affects Individual Treatment Susceptibility Ex Vivo

The Challenge to Stabilize, Extract and Analyze Urinary Cell-Free DNA (ucfDNA) during Clinical Routine

Abstract P2-01-16: Targeted sequencing of plasma-derived vs. urinary cfDNA from patients with triple negative breast cancer

Analysis of disseminated tumor cells (DTCs) in primary breast cancer patients with various molecular subtypes

In search for new targets: Differences of HER2 receptor expression between CNB and synchronous axillary lymph node metastases in 205 patients

Abstract 4604: Can breast cancer cells be distinguished from blood cells by mechanical parameters? A label-free CTC detection approach

Can tumor cells be distinguished from blood cells by mechanical parameters? A label-free CTC detection approach

Abstract P1-03-01: Heterogeneity between core needle biopsy and primary tumor tissue in early breast cancer patients: Comparison of intrinsic subtypes after different treatment regimes

Heterogeneity between core needle biopsy and synchronous axillary lymph node metastases in early breast cancer patients: Comparison of HER2, estrogen and progesterone receptor expression profiles during primary treatment regime

Development of a personalized ex vivo drug screening test for patients with ovarian cancer

Die CAPTOR-BC-Studie

An Observational Study on Breast Cancer Survival and Lifestyle Related Risk Factors

Abstract 6693: Stability of urinary cell-free DNA and detection of T790M variant

Individual profiling of circulating tumor cell composition in patients with non-small cell lung cancer receiving platinum based treatment

The Potential Use of Urinary CtDNA Profiling in the Treatment of Breast Cancer

Circulating tumor cell composition and outcome in patients with solid tumors

CDK4/6 Inhibition - Therapy Sequences and the Quest to Find the Best Biomarkers - an Overview of Current Programs

Suchergebnisse filtern